Health Minister Aaron Motsoaledi came under sustained fire in Parliament on Wednesday as MPs from across the political divide turned on him over the Department of Health’s handling of the R15.5 billion antiretroviral tender that was struck down by the High Court last month.
What was meant to be an accountability session of the Portfolio Committee on Health quickly turned into a political ambush, with MPs accusing Motsoaledi of sitting on warnings, shielding officials and presiding over a procurement disaster that could have disrupted treatment for millions of South Africans living with HIV.
The tension centred on the national ARV tender, which was challenged in court by unsuccessful bidders Cipla and Hetero Drugs South Africa.
The Pretoria High Court found the award unlawful, raising serious questions about how contracts were handed to Barrs Pharmaceuticals and Innovata Pharmaceuticals, two companies linked through common ownership under the Avacare Health Group.
The committee told Motsoaledi it had warned him as early as February that the tender was not above board. It took a court judgment to declare it invalid.
ActionSA MP Tebogo Letlape went further, calling for a commission of inquiry into health tenders to probe alleged collusion and anti-competitive conduct among pharmaceutical companies.
Committee chairperson Faith Muthambi led the charge, saying it was unacceptable that a month after the court ruled against the department, not a single official had faced consequences.
Muthambi demanded the names of every official who sat on the bid evaluation and bid adjudication committees, and warned that some of those officials could still be involved in Wednesday’s discussions.
Turning to newly-appointed Director-General Thembisile Xulu, Muthambi was blunt: “By now you should have acted. These are the officials you should have suspended with immediate effect, as a consequence of that court judgment.”
The EFF’s Naledi Chirwa was even more scathing, accusing Motsoaledi of failing to act when Parliament first raised the alarm.
“You are found wanting. That’s the matter of fact. You did nothing about it. We told you about this on 18 February, and you decided you are not going to do anything about it,” Chirwa said.
The EFF has now upped the ante, calling for Motsoaledi’s immediate resignation.
In a statement issued on Wednesday, the party said the minister could no longer hide behind officials and claim he had nothing to do with tenders.
“The EFF rejects this convenient distancing from political responsibility. A Minister cannot preside over a Department responsible for the health of millions of people and then claim ignorance when billions in public procurement are surrounded by serious irregularities,” the party said.
The EFF revealed that it had written to the committee chairperson on 14 February, requesting an urgent meeting to discuss the tender before the situation spiralled out of control.
During the 18 February proceedings, Chirwa raised concerns about the awarding of contracts to Barrs and Innovata, suspicious similarities in their prices — including a difference of only R1 for a particular product — and the department’s failure to conduct proper financial evaluations to establish whether the companies could fulfil multibillion-rand contracts.
The party also questioned the implications of the Public Finance Management Act, the accountability of officials, and called for a Special Investigating Unit probe and a restart of the tender process.
Instead of answers, the EFF said, Motsoaledi distanced himself from procurement, insisting he did not involve himself in tenders and relied on information provided by officials.
The court’s findings have since vindicated Parliament’s concerns. The court found that Innovata and Viatris did not possess valid manufacturing licences for their Isando manufacturing site when the tender closed. It also identified serious irregularities in the allocation of local manufacturing preference and historically disadvantaged individual (HDI) points, and directed the department to investigate whether Barrs and Innovata had prepared their bids independently.
The Minister and Director-General were also ordered to pay Cipla’s legal costs.
The EFF also flagged that Barrs and Innovata later entered business rescue in December 2025, with Hetero becoming involved in the resulting supply arrangements — developments it said reinforced the need for a full investigation.
Motsoaledi told the committee he could not get directly involved in procurement matters. He said a forensic investigation would be conducted.
He also pointed the finger at former Director-General Sandile Buthelezi, who was arrested by the Hawks in March on a different tender matter, saying Buthelezi should not have signed off on the ARV contracts after conflicting information was presented to him by the two bid committees.
That explanation did little to calm MPs, who accused the minister of shifting blame while officials implicated in the scandal remained in their posts.
Angered by the responses, the committee resolved to meet in private to decide on a way forward.
The EFF is now demanding full disclosure of the tender evaluation, adjudication and financial due-diligence reports, accountability for officials responsible for the unlawful procurement decisions, a comprehensive plan to protect uninterrupted ARV supplies while the affected awards are reconsidered, and the accelerated establishment of state pharmaceutical manufacturing capacity to end South Africa’s dependence on private suppliers.
